Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancer.
Ovarian cancer stem-like cells (CSCs) have been implicated in tumor recurrence, metastasis, and...
Read More